| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Odyssey Health, Inc. | President & CEO, Director | Stock Option (Right to Buy) | 500,000 | $50,000 | $0.1000 | 28 Jun 2024 | Direct |
| ORAGENICS INC | President | Employee Option (Right to Buy) | 100,000 | 19 Sep 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| OGEN | ORAGENICS INC | 19 Sep 2024 | 1 | $0 | 4 | President | 20 Sep 2024, 21:15 |
| ODYY | Odyssey Health, Inc. | 28 Jun 2024 | 1 | +$50,000 | 4 | President & CEO, Director | 16 Jul 2024, 17:10 |
| ODYY | Odyssey Health, Inc. | 29 Dec 2023 | 1 | +$50,000 | 4 | President & CEO, Director | 02 Jan 2024, 17:10 |
| OGEN | ORAGENICS INC | 28 Dec 2023 | 1 | $0 | 4 | President | 02 Jan 2024, 17:09 |
| OGEN | ORAGENICS INC | 28 Dec 2023 | 0 | $0 | 3 | President | 02 Jan 2024, 16:40 |
| ODYY | Odyssey Health, Inc. | 12 Jan 2023 | 2 | +$150,000 | 4 | President & CEO, Director | 13 Jan 2023, 16:16 |
| ODYY | Odyssey Health, Inc. | 02 Sep 2022 | 1 | -$244,950 | 4 | President & CEO, Director | 15 Sep 2022, 16:16 |
| ODYY | Odyssey Health, Inc. | 19 May 2022 | 2 | +$225,000 | 4 | President/CEO, Director | 08 Jun 2022, 17:17 |